cKIT
Showing 1 - 25 of 35
Advanced Melanoma Trial in Beijing (JS001+Imatinib mesylate)
Recruiting
- Advanced Melanoma
- JS001+Imatinib mesylate
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Mar 2, 2022
Correlate Tracer Uptake to TCell Tumor Infiltration & CkIT Benefit Trial in Stanford, Portland ([18F]F-AraG)
Not yet recruiting
- Solid Tumor
- Fluorine F 18 Ara-G
-
Palo Alto, CaliforniaStanford University
Feb 1, 2022
Advanced Non Small Cell Lung Cancer Trial ([18F]F-AraG)
Not yet recruiting
- Advanced Non Small Cell Lung Cancer
- (no location specified)
Oct 24, 2023
Adjuvant Radiotherapy on Circulating Cells in Breast Cancer
Completed
- Breast Cancer
- blood samples collection
-
Lugano, Ticino, SwitzerlandClinica Luganese Moncucco
Apr 26, 2021
NSCLC Trial in Iowa City ([18F]F-ARAG PET)
Not yet recruiting
- Non-small Cell Lung Cancer
- [18F]F-ARAG PET
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Oct 10, 2023
Colorectal Cancer Stage IV Trial in Napoli (Panitumumab)
Completed
- Colorectal Cancer Stage IV
-
Napoli, ItalyIstituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pasc
Apr 6, 2022
Apheresis to Obtain Plasma or White Blood Cells for Laboratory
Terminated
- Leukopheresis
- Plasmapheresis
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 9, 2021
Non Small Cell Lung Cancer Trial in Palo Alto, Sacramento, Stony Brook ([18F]F AraG)
Recruiting
- Non Small Cell Lung Cancer
- [18F]F AraG
-
Palo Alto, California
- +2 more
Apr 11, 2022
microVAScular Dysfunction in Covid-19 ARDS
Recruiting
- ARDS, Human
- COVID-19 Acute Respiratory Distress Syndrome
- alveolar dead-space quantification
- +2 more
-
Paris, FranceHôpital européen Georges Pompidou
Jan 17, 2022
Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
Recruiting
- Breast Cancer
- +10 more
-
Hamilton, Ontario, Canada
- +6 more
Apr 21, 2022
Rare Tumor Trial (Almonertinib 110 MG, Dacomitinib 45 MG, Alectinib 150 MG)
Not yet recruiting
- Rare Tumor
- Almonertinib 110 MG
- +10 more
- (no location specified)
Jul 31, 2020
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022
Cancer of Rectum Trial in Matosinhos (Analysis of cfDNA)
Recruiting
- Cancer of Rectum
- Analysis of cfDNA
-
Matosinhos, Porto, PortugalHospital Pedro Hispano
Aug 25, 2021
Adenoid Cystic Carcinomas of the Salivary Glands Trial in Milan (Lenvatinib)
Completed
- Adenoid Cystic Carcinomas of the Salivary Glands
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Aug 29, 2019
Glioblastoma, Glioblastoma Multiforme, Gliosarcoma Trial run by the NCI (topotecan, pazopanib)
Completed
- Glioblastoma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 3, 2020
Metastatic Melanoma Trial in Reims (patients with metastatic melanoma)
Unknown status
- Metastatic Melanoma
- patients with metastatic melanoma
-
Reims, FranceChu de Reims
Dec 13, 2019
Gastro-intestinal Stromal Tumours Trial in Villejuif (oral masitinib)
Completed
- Gastro-intestinal Stromal Tumours
- oral masitinib
-
Villejuif, FranceLecesne
Dec 8, 2018
French Clinical Datbase of Melanoma Patients (RIC-Mel)
Unknown status
- Melanoma (Skin)
-
Nantes, FranceNantes University Hospital
Nov 20, 2018
Hepatocellular Carcinoma Trial in Riyadh (Sorafenib)
Recruiting
- Hepatocellular Carcinoma
-
Riyadh, Saudi ArabiaKing Saud University Medical City
Aug 19, 2019
Tumor Pathway Activations Inhibited by Dovitinib Trial in United States (Dovitinib (TKI258))
Completed
- Tumor Pathway Activations Inhibited by Dovitinib
- Dovitinib (TKI258)
-
Birmingham, Alabama
- +48 more
Jan 30, 2017